China In Vitro Diagnostics Market will be USD 22.3 Billion by 2026. Forecast by Segment (Clinical Chemistry, Immunoassay, Molecular Testing, Microbiology, Hematology, SMBG, Point of Care Testing, Coagulation), Company Analysis.
(I-BusinessNews.Com, December 16, 2020 ) In China, in vitro diagnostic industry has been emerged since the 1980s, and now the key players are manufacturing from single and straight forward products to complete industrial chains. The 21st century brought a rapid development in China IVD industry, where all the tools such as reagents and instruments are produced in-house. Nowadays the global companies have put their steps in China and engaged in business activities of in vitro diagnostic industry. The increasing number of test volumes related to clinical chemistry, immunoassay, haematology, coagulation and microbiology are in high demand. They are acting as a catalysing role for the growth of the China IVD industry. According to Renub Research analysis, China In Vitro Diagnostics Market will be USD 22.3 Billion by 2026.
The major growth drivers for China IVD industry are increasing demand from the middle class for high-quality healthcare products, and rising incidences of lifestyle diseases. In China, there has been massive expenditure in every healthcare segment in the areas of pharmaceuticals, medical devices, and traditional Chinese medicines. The significant barriers for China IVD industry are the local manufacturers lagging by the adoption of advance technology.
In October 2020, Roche diagnostics launched the product “RocheÃ‚Â’s Tecentriq” with Avastin which was approved by CFDA for the treatment of liver cancer. The outbreak of Covid-19 has impacted the IVD products by playing a vital role in the diagnosis of the coronavirus symptoms.
Renub Research report titled Ã‚Â“China InÃ‚Â–Vitro Diagnostics (IVD) Market, By Segment [Clinical Chemistry, Immunoassay, Molecular Testing, Microbiology, Hematology, Self Monitoring of Blood Glucose (SMBG), Point of Care Testing (POCT), Coagulation], Companies (Roche Diagnostics, Sysmex Corporation, Mindray Medical International Limited, Shanghai Kehua Bio-Engineering Co. Ltd., Abbott Laboratories & Others)Ã‚Â” studies the China IVD Industry.
Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=china-in-vitro-diagnostics-market-p.php
By Segment Ã‚Â– The Report Studies the Market of the following 8 Categories:
1. Clinical Chemistry
3. Molecular Testing
6. Self Monitoring of Blood Glucose (SMBG)
7. Point of Care Testing (POCT)
Key Players covered in the report which has been studied from 3 viewpoints
Ã‚Â• Initiatives & Recent Developments
Companies covered in this report
1. Roche Diagnostics
2. Sysmex Corporation
3. Mindray Medical International Limited
4. Shanghai Kehua Bio-Engineering Co. Ltd.
5. Abbott Laboratories
Industry Related Opportunity:
Japan In Vitro Diagnostics Market: https://www.renub.com/japan-in-vitro-diagnostics-market-p.php
China In Vitro Fertilization Market: https://www.renub.com/china-in-vitro-fertilization-market-p.php
Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises of major players in Life Sciences, Information Technology, Telecom, Financial Services (Banking, Insurance), Energy, Retail, Manufacturing, Automotive, and Social sector. Our clients rely on our market analysis and data to make informed knowledgeable decisions. We are regarded as one of the best providers of knowledge. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.
Market Research, Bus